W. Wuyts (Rotselaar, Belgium), M. Veltkamp (De Meern, Netherlands), S. Jouneau (Rennes Cedex, France), I. Strambu (Bucuresti 5, Romania)
The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis
T. Lodhi (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), P. Rivera Ortega (Manchester, United Kingdom), H. Morris (Manchester, United Kingdom), T. Marshall (Manchester, United Kingdom), K. Zakis (Manchester, United Kingdom), T. Garfoot (Manchester, United Kingdom), C. Hayton (Manchester, United Kingdom), M. Greaves (Manchester, United Kingdom), J. Blaikley (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom)
|   |
Nationwide survey of physicians' attitude and approach to the clinical evaluation of interstitial lung disease in Singapore
F. Teo (Singapore, Singapore), G. Chai (Singapore, Singapore), S. Low (Singapore, Singapore), C. Teoh (Singapore, Singapore), T. Tay (Singapore, Singapore), M. Kokosi (London, United Kingdom), C. Choo (Singapore, Singapore), S. Tan (Singapore, Singapore), J. Tan (Singapore, Singapore), L. Teo (Singapore, Singapore), Y. Ng (Singapore, Singapore), G. Kaw (Singapore, Singapore), M. Takahashi (Japan, Japan), W. Wuyts (Leuven, Belgium), F. Chua (London, United Kingdom), V. Cottin (Lyon, France), S. Walsh (London, United Kingdom), Y. Chan (Singapore, Singapore)
| |
Absence of early metabolic response assessed by 18F-FDG PET-CT after initiation of antifibrotic drugs in IPF patients.
B. Bondue (Brussels, Belgium), A. Castiaux (Brussels, Belgium), G. Van Simaeys (Brussels, Belgium), C. Mathey (Brussels, Belgium), F. Sherer (Gosselies, Belgium), D. Egrise (Brussels, Belgium), S. Lacroix (Brussels, Belgium), F. Huaux (Brussels, Belgium), G. Doumont (Gosselies, Belgium), S. Goldman (Brussels, Belgium)
| |
Multidisciplinary discussion (MDD) in IPF diagnosis: the experience of an Italian Centre
E. Torricelli (Florence, Italy), E. Rosi (Florence, Italy), L. Turi (Florence, Italy), C. Lo Conte (Florence, Italy), C. Piccioli (Florence, Italy), E. Vivarelli (Florence, Italy), P. Parronchi (Florence, Italy), C. Moroni (Florence, Italy), A. Bindi (Florence, Italy), E. Cavigli (Florence, Italy), M. Bartolucci (Florence, Italy), V. Luzzi (Florence, Italy), M. Bezzi (Florence, Italy), D. Viggiano (Florence, Italy), L. Voltolini (Florence, Italy), E. Bargagli (Florence, Italy)
| |
Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib
Y. Zhang (Nanjing, China), K. Jones (SF, United States of America), N. Achtar-Zadeh (SF, United States of America), J. Kukreja (SF, United States of America), P. Wolters (SF, United States of America), (SF, United States of America)
| |
Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review
C. Hayton (Manchester, United Kingdom), D. Terrington (Norwich, United Kingdom), A. Wilson (Norwich, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom)
| |
Frequency of cough versus dyspnoea as the first recorded symptom of idiopathic pulmonary fibrosis
D. Thickett (Birmingham, United Kingdom), J. Voorham (Singapore, Singapore), R. Ryan (Singapore, Singapore), R. Jones (Plymouth, United Kingdom), R. Coker (London, United Kingdom), A. Wilson (Norwich, United Kingdom), S. Yang (Singapore, Singapore), M. Ow (Singapore, Singapore), P. Raju (Singapore, Singapore), I. Chaudry (Singapore, Singapore), V. Carter (Singapore, Singapore), D. Price (Singapore, Singapore)
| |
MUC5B gene in a cohort of Lebanese patients with idiopathic pulmonary fibrosis
G. Dabar (Beirut, Lebanon), Z. Aoun (Beirut, Lebanon), M. Riachi (Beirut, Lebanon), J. Boutros (Beirut, Lebanon)
| |
Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis
S. moon (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), S. Kwak (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea)
| |
High-resolution computed tomography fibrosis score and pulmonary function tests in interstitial lung disease: Is there any correlation?
R. Fessi (Tunis , Tunisia), B. Ourari (Tunis , Tunisia), J. Ben Amar (Tunis , Tunisia), H. Zaibi (Tunis , Tunisia), S. Azzabi (Tunis , Tunisia), M. Baccar (Tunis , Tunisia), H. Aouina (Tunis , Tunisia)
| |
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis
S. Majewski (Lodz, Poland), D. Tworek (Lodz, Poland), K. Szewczyk (Lodz, Poland), Z. Kurmanowska (Lodz, Poland), A. Antczak (Lodz, Poland), P. Górski (Lodz, Poland), W. Piotrowski (Lodz, Poland)
| |
Looking for airways periostin in patients with interstitial lung diseases.
G. Scioscia (FOGGIA, Italy), D. Lacedonia (FOGGIA, Italy), P. Soccio (FOGGIA, Italy), F. Simone (FOGGIA, Italy), I. Caccavo (FOGGIA, Italy), R. Sabato (FOGGIA, Italy), E. Giuffreda (FOGGIA, Italy), G. Carpagnano (FOGGIA, Italy), M. Foschino Barbaro (FOGGIA, Italy)
| |
Ca 19-9 serum levels in patients with end-stage Idiopathic Pulmonary Fibrosis (IPF)
E. Balestro (Padova, Italy), E. Cocconcelli (Padova, Italy), D. Biondini (Padova, Italy), F. Fracasso (Padova, Italy), G. Castelli (Padova, Italy), G. Marulli (Padova, Italy), F. Rea (Padova, Italy), M. Cosio (Padova, Italy), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy)
| |
In vivo optical imaging for low-risk microscopic diagnosis of IPF
L. Hariri (Boston, United States of America), A. Muniappan (Boston, United States of America), C. Keyes (Boston, United States of America), J. Wain (Boston, United States of America), M. Lanuti (Boston, United States of America), C. Morse (Boston, United States of America), H. Gaissert (Boston, United States of America), H. Auchincloss (Boston, United States of America), D. Adams (Boston, United States of America), M. Szabari (Boston, United States of America), A. Sharma (Boston, United States of America), T. Colby (Scottsdale, United States of America), M. Mino-Kenudson (Boston, United States of America), E. Mark (Boston, United States of America), R. Kradin (Boston, United States of America), H. Pahlevaninezhad (Boston, United States of America), H. Goulart (Boston, United States of America), L. Liang (Boston, United States of America), A. Tager (Boston, United States of America), M. Suter (Boston, United States of America)
| |
Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis?
N. Przysucha (Warsaw, Poland), K. Gorska (Warsaw, Poland), M. Paplinska (Warsaw, Poland), P. Nejman-Gryz (Warsaw, Poland), M. Proboszcz (Warsaw, Poland), R. Krenke (Warsaw, Poland)
| |
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results.
G. Pitsidianakis (HERAKLION,CRETE, Greece), M. Bolaki (HERAKLION,CRETE, Greece), E. Vasarmidi (HERAKLION,CRETE, Greece), K. Karagiannis (HERAKLION,CRETE, Greece), K. Anotniou (HERAKLION,CRETE, Greece), N. Tzanakis (HERAKLION,CRETE, Greece)
| |
Roles of transthoracic lung ultrasonography in diagnosis of interstitial lung disease: correlation with HRCT, vital capacity, diffusing of the lung for monoxide test
M. Man (CLUJ-NAPOCA, Romania), A. Parau (CLUJ-NAPOCA, Romania), A. Ruscovan (CLUJ-NAPOCA, Romania), M. Pop (CLUJ-NAPOCA, Romania), R. Rajnoveanu (CLUJ-NAPOCA, Romania), B. Domokos Hancu (CLUJ-NAPOCA, Romania)
| |
Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?
H. Wu (Lancaster, United Kingdom), J. Wingfield-Digby (Lancaster, United Kingdom), T. Gatheral (Lancaster, United Kingdom)
| |
Correlation between HRTC appearance and histopathological features in the diagnosis of interstitial lung diseases
G. Verri (Turin , Italy), P. Lyberis (Turin , Italy), P. Solidoro (Turin , Italy), L. Mercante (Turin , Italy), M. Bardessono (Turin , Italy), M. Roffinella (Turin , Italy), E. Ruffini (Turin , Italy), P. Filosso (Turin , Italy), C. Bucca (Turin , Italy), A. Oliaro (Turin , Italy), F. Guerrera (Turin , Italy)
| |